Bayer AG's top pharmaceutical products based on revenue 2021-2023

Bayer AG is an international pharmaceutical and agriculture company. In 2023, their top pharmaceutical product was once again Xarelto, a blood clot reducing medication used in the treatment of coronary artery disease. During that year Xarelto generated around 4.1 billion U.S. dollars in revenues for Bayer. The second highest revenue generating pharmaceutical for Bayer was Eylea, which generated about 3.2 billion U.S. dollars at that time.

Bayer’s company profile

Bayer is a German pharmaceutical and agriculture company with several segments such as Pharmaceuticals and Crop Science. Bayer operates on a global level. Bayer’s largest revenue-generating segment is Crop Science, followed by the Pharmaceuticals segment. Bayer is among the top 20 pharmaceutical companies globally based on prescription drug revenue.

Global pharmaceuticals

The top pharmaceutical companies based on research and development expenses include big names such as Roche, Johnson & Johnson, and Novartis. These companies rely heavily on the research and development of new drugs. Currently the top pharmaceutical products globally include AbbVie’s Humira, Pfizer’s Eliquis, and Merck's Keytruda. The worldwide pharmaceutical market has been growing steadily in recent years and estimates suggest that there will be many new opportunities for these top companies to develop new drugs.